These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34593893)

  • 21. Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in vitro and in vivo models.
    Bargiela A; Sabater-Arcis M; Espinosa-Espinosa J; Zulaica M; Lopez de Munain A; Artero R
    Proc Natl Acad Sci U S A; 2019 Dec; 116(50):25203-25213. PubMed ID: 31754023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1.
    Dansithong W; Paul S; Comai L; Reddy S
    J Biol Chem; 2005 Feb; 280(7):5773-80. PubMed ID: 15546872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. (CTG)n repeat-mediated dysregulation of MBNL1 and MBNL2 expression during myogenesis in DM1 occurs already at the myoblast stage.
    André LM; van Cruchten RTP; Willemse M; Wansink DG
    PLoS One; 2019; 14(5):e0217317. PubMed ID: 31116797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac elav-type RNA-binding protein (ETR-3) binds to RNA CUG repeats expanded in myotonic dystrophy.
    Lu X; Timchenko NA; Timchenko LT
    Hum Mol Genet; 1999 Jan; 8(1):53-60. PubMed ID: 9887331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model.
    Angelbello AJ; Rzuczek SG; Mckee KK; Chen JL; Olafson H; Cameron MD; Moss WN; Wang ET; Disney MD
    Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7799-7804. PubMed ID: 30926669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bruno-3 regulates sarcomere component expression and contributes to muscle phenotypes of myotonic dystrophy type 1.
    Picchio L; Legagneux V; Deschamps S; Renaud Y; Chauveau S; Paillard L; Jagla K
    Dis Model Mech; 2018 May; 11(5):. PubMed ID: 29716962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Daunorubicin reduces MBNL1 sequestration caused by CUG-repeat expansion and rescues cardiac dysfunctions in a
    Chakraborty M; Sellier C; Ney M; Pascal V; Charlet-Berguerand N; Artero R; Llamusi B
    Dis Model Mech; 2018 Apr; 11(4):. PubMed ID: 29592894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2.
    Carpentier C; Ghanem D; Fernandez-Gomez FJ; Jumeau F; Philippe JV; Freyermuth F; Labudeck A; Eddarkaoui S; Dhaenens CM; Holt I; Behm-Ansmant I; Marmier-Gourrier N; Branlant C; Charlet-Berguerand N; Marie J; Schraen-Maschke S; Buée L; Sergeant N; Caillet-Boudin ML
    Biochim Biophys Acta; 2014 Apr; 1842(4):654-64. PubMed ID: 24440524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Plant-derived Alkaloids with Therapeutic Potential for Myotonic Dystrophy Type I.
    Herrendorff R; Faleschini MT; Stiefvater A; Erne B; Wiktorowicz T; Kern F; Hamburger M; Potterat O; Kinter J; Sinnreich M
    J Biol Chem; 2016 Aug; 291(33):17165-77. PubMed ID: 27298317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The hallmarks of myotonic dystrophy type 1 muscle dysfunction.
    Ozimski LL; Sabater-Arcis M; Bargiela A; Artero R
    Biol Rev Camb Philos Soc; 2021 Apr; 96(2):716-730. PubMed ID: 33269537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscleblind protein, MBNL1/EXP, binds specifically to CHHG repeats.
    Kino Y; Mori D; Oma Y; Takeshita Y; Sasagawa N; Ishiura S
    Hum Mol Genet; 2004 Mar; 13(5):495-507. PubMed ID: 14722159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction.
    Chakraborty M; Selma-Soriano E; Magny E; Couso JP; Pérez-Alonso M; Charlet-Berguerand N; Artero R; Llamusi B
    Dis Model Mech; 2015 Dec; 8(12):1569-78. PubMed ID: 26515653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Effects of the CTG Repeats in Mutant Dystrophia Myotonica Protein Kinase Gene.
    Llamusí B; Artero R
    Curr Genomics; 2008 Dec; 9(8):509-16. PubMed ID: 19516957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2.
    Mankodi A; Urbinati CR; Yuan QP; Moxley RT; Sansone V; Krym M; Henderson D; Schalling M; Swanson MS; Thornton CA
    Hum Mol Genet; 2001 Sep; 10(19):2165-70. PubMed ID: 11590133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MBNL1 reverses the proliferation defect of skeletal muscle satellite cells in myotonic dystrophy type 1 by inhibiting autophagy via the mTOR pathway.
    Song KY; Guo XM; Wang HQ; Zhang L; Huang SY; Huo YC; Zhang G; Feng JZ; Zhang RR; Ma Y; Hu QZ; Qin XY
    Cell Death Dis; 2020 Jul; 11(7):545. PubMed ID: 32683410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modifications to toxic CUG RNAs induce structural stability, rescue mis-splicing in a myotonic dystrophy cell model and reduce toxicity in a myotonic dystrophy zebrafish model.
    deLorimier E; Coonrod LA; Copperman J; Taber A; Reister EE; Sharma K; Todd PK; Guenza MG; Berglund JA
    Nucleic Acids Res; 2014 Nov; 42(20):12768-78. PubMed ID: 25303993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2.
    Cardani R; Mancinelli E; Rotondo G; Sansone V; Meola G
    Eur J Histochem; 2006; 50(3):177-82. PubMed ID: 16920640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A CTG repeat-selective chemical screen identifies microtubule inhibitors as selective modulators of toxic CUG RNA levels.
    Reddy K; Jenquin JR; McConnell OL; Cleary JD; Richardson JI; Pinto BS; Haerle MC; Delgado E; Planco L; Nakamori M; Wang ET; Berglund JA
    Proc Natl Acad Sci U S A; 2019 Oct; 116(42):20991-21000. PubMed ID: 31570586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats.
    Dhaenens CM; Schraen-Maschke S; Tran H; Vingtdeux V; Ghanem D; Leroy O; Delplanque J; Vanbrussel E; Delacourte A; Vermersch P; Maurage CA; Gruffat H; Sergeant A; Mahadevan MS; Ishiura S; Buée L; Cooper TA; Caillet-Boudin ML; Charlet-Berguerand N; Sablonnière B; Sergeant N
    Exp Neurol; 2008 Apr; 210(2):467-78. PubMed ID: 18177861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Ligand That Targets CUG Trinucleotide Repeats.
    Li J; Matsumoto J; Bai LP; Murata A; Dohno C; Nakatani K
    Chemistry; 2016 Oct; 22(42):14881-14889. PubMed ID: 27573860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.